vs
太平洋生物科学（ASMB）与TRANSACT TECHNOLOGIES INC（TACT）财务数据对比。点击上方公司名可切换其他公司
TRANSACT TECHNOLOGIES INC的季度营收约是太平洋生物科学的1.1倍（$11.5M vs $10.8M），太平洋生物科学同比增速更快（57.6% vs 11.9%），TRANSACT TECHNOLOGIES INC自由现金流更多（$589.0K vs $-15.2M）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
该公司相关归属主体罗珀技术公司是一家控股集团，主要投资控股科技领域的各类企业，业务覆盖多个科技细分赛道，依托旗下子公司开展多元化科技业务布局。
ASMB vs TACT — 直观对比
营收规模更大
TACT
是对方的1.1倍
$10.8M
营收增速更快
ASMB
高出45.7%
11.9%
自由现金流更多
TACT
多$15.8M
$-15.2M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $11.5M |
| 净利润 | $-9.2M | — |
| 毛利率 | — | 47.6% |
| 营业利润率 | -100.9% | -10.1% |
| 净利率 | -85.2% | — |
| 营收同比 | 57.6% | 11.9% |
| 净利润同比 | 4.3% | — |
| 每股收益（稀释后） | $-0.72 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBTACT
| Q4 25 | — | $11.5M | ||
| Q3 25 | $10.8M | $13.2M | ||
| Q2 25 | $9.6M | $13.8M | ||
| Q1 25 | $9.4M | $13.1M | ||
| Q4 24 | $7.4M | $10.2M | ||
| Q3 24 | $6.8M | $10.9M | ||
| Q2 24 | $8.5M | $11.6M | ||
| Q1 24 | $5.8M | $10.7M |
净利润ASMBTACT
| Q4 25 | — | — | ||
| Q3 25 | $-9.2M | $15.0K | ||
| Q2 25 | $-10.2M | $-143.0K | ||
| Q1 25 | $-8.8M | $19.0K | ||
| Q4 24 | — | — | ||
| Q3 24 | $-9.6M | $-551.0K | ||
| Q2 24 | $-11.2M | $-319.0K | ||
| Q1 24 | $-9.1M | $-1.0M |
毛利率ASMBTACT
| Q4 25 | — | 47.6% | ||
| Q3 25 | — | 49.8% | ||
| Q2 25 | — | 48.2% | ||
| Q1 25 | — | 48.7% | ||
| Q4 24 | — | 44.2% | ||
| Q3 24 | — | 48.1% | ||
| Q2 24 | — | 52.7% | ||
| Q1 24 | — | 52.6% |
营业利润率ASMBTACT
| Q4 25 | — | -10.1% | ||
| Q3 25 | -100.9% | 0.1% | ||
| Q2 25 | -115.2% | -1.9% | ||
| Q1 25 | -105.5% | -0.1% | ||
| Q4 24 | — | -10.3% | ||
| Q3 24 | -160.1% | -7.7% | ||
| Q2 24 | -143.0% | -3.8% | ||
| Q1 24 | -185.5% | -12.2% |
净利率ASMBTACT
| Q4 25 | — | — | ||
| Q3 25 | -85.2% | 0.1% | ||
| Q2 25 | -105.9% | -1.0% | ||
| Q1 25 | -93.6% | 0.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | -140.4% | -5.1% | ||
| Q2 24 | -130.7% | -2.8% | ||
| Q1 24 | -156.9% | -9.7% |
每股收益（稀释后）ASMBTACT
| Q4 25 | — | $-0.11 | ||
| Q3 25 | $-0.72 | $0.00 | ||
| Q2 25 | $-1.33 | $-0.01 | ||
| Q1 25 | $-1.17 | $0.00 | ||
| Q4 24 | — | $-0.80 | ||
| Q3 24 | $-1.51 | $-0.06 | ||
| Q2 24 | $-1.98 | $-0.03 | ||
| Q1 24 | $-1.66 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | $20.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $182.7M | $31.1M |
| 总资产 | $240.0M | $44.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASMBTACT
| Q4 25 | — | $20.4M | ||
| Q3 25 | $22.5M | $20.0M | ||
| Q2 25 | $24.0M | $17.7M | ||
| Q1 25 | $23.4M | $14.2M | ||
| Q4 24 | $38.3M | $14.4M | ||
| Q3 24 | $28.5M | $11.3M | ||
| Q2 24 | $19.2M | $11.1M | ||
| Q1 24 | $18.7M | $10.6M |
股东权益ASMBTACT
| Q4 25 | — | $31.1M | ||
| Q3 25 | $182.7M | $31.8M | ||
| Q2 25 | $18.1M | $31.3M | ||
| Q1 25 | $27.1M | $30.9M | ||
| Q4 24 | $33.4M | $30.6M | ||
| Q3 24 | $26.0M | $38.4M | ||
| Q2 24 | $34.7M | $38.5M | ||
| Q1 24 | $32.6M | $38.6M |
总资产ASMBTACT
| Q4 25 | — | $44.8M | ||
| Q3 25 | $240.0M | $45.0M | ||
| Q2 25 | $80.8M | $44.5M | ||
| Q1 25 | $99.0M | $44.2M | ||
| Q4 24 | $119.2M | $44.0M | ||
| Q3 24 | $100.3M | $50.5M | ||
| Q2 24 | $115.3M | $50.4M | ||
| Q1 24 | $119.9M | $51.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $609.0K |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | $589.0K |
| 自由现金流率自由现金流/营收 | -140.7% | 5.1% |
| 资本支出强度资本支出/营收 | 0.4% | 0.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $7.6M |
8季度趋势，按日历期对齐
经营现金流ASMBTACT
| Q4 25 | — | $609.0K | ||
| Q3 25 | $-15.1M | $3.6M | ||
| Q2 25 | $-16.8M | $3.6M | ||
| Q1 25 | $-23.4M | $-161.0K | ||
| Q4 24 | $-51.1M | $2.4M | ||
| Q3 24 | $-15.2M | $327.0K | ||
| Q2 24 | $-17.1M | $636.0K | ||
| Q1 24 | $-18.4M | $-1.5M |
自由现金流ASMBTACT
| Q4 25 | — | $589.0K | ||
| Q3 25 | $-15.2M | $3.6M | ||
| Q2 25 | — | $3.6M | ||
| Q1 25 | — | $-171.0K | ||
| Q4 24 | $-51.1M | $2.4M | ||
| Q3 24 | — | $259.0K | ||
| Q2 24 | $-17.1M | $499.0K | ||
| Q1 24 | $-18.4M | $-1.6M |
自由现金流率ASMBTACT
| Q4 25 | — | 5.1% | ||
| Q3 25 | -140.7% | 27.1% | ||
| Q2 25 | — | 25.9% | ||
| Q1 25 | — | -1.3% | ||
| Q4 24 | -695.2% | 23.2% | ||
| Q3 24 | — | 2.4% | ||
| Q2 24 | -200.6% | 4.3% | ||
| Q1 24 | -317.7% | -14.9% |
资本支出强度ASMBTACT
| Q4 25 | — | 0.2% | ||
| Q3 25 | 0.4% | 0.5% | ||
| Q2 25 | 0.0% | 0.1% | ||
| Q1 25 | 0.0% | 0.1% | ||
| Q4 24 | 0.4% | 0.1% | ||
| Q3 24 | 0.0% | 0.6% | ||
| Q2 24 | 0.2% | 1.2% | ||
| Q1 24 | 0.2% | 1.0% |
现金转化率ASMBTACT
| Q4 25 | — | — | ||
| Q3 25 | — | 242.00× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -8.47× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
